Treatment of age-related macular degeneration: focus on ranibizumab

Ranibizumab, a humanized antigen-binding fragment (Fab) that binds all isoforms of VEGF-A, significantly slows down loss of vision and causes significant visual improvement in many patients with choroidal neovascularization (CNV) due to exudative age-related macular degeneration (AMD). These benefit...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Spitzer, Martin S, Ziemssen, Focke, Bartz-Schmidt, Karl U, Gelisken, Faik, Szurman, Peter
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2008
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2698673/
https://ncbi.nlm.nih.gov/pubmed/19668384
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky